Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Brain Research|January 31, 2006
The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemiaAlessia Melani, Marco Gianfriddo, Maria Giuliana Vannucchi, et al.
European Journal of Medicinal Chemistry|March 30, 2013
Anticancer activity of novel hybrid molecules containing 5-benzylidene thiazolidine-2,4-dioneRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Handbook of Experimental Pharmacology|July 30, 2009
Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineeringKenneth A Jacobson, Athena M Klutz, Dilip K Tosh, et al.
Journal of Medicinal Chemistry|June 14, 2011
Convergent synthesis and biological evaluation of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as microtubule targeting agentsRomeo Romagnoli, Pier Giovanni Baraldi, Andrea Brancale, et al.
Molecular Pharmacology|January 26, 2002
A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical studyStefania Gessi, Katia Varani, Stefania Merighi, et al.
European Journal of Medicinal Chemistry|May 24, 2015
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH)Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.
Bioorganic & Medicinal Chemistry|March 12, 2002
Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activityPier Giovanni Baraldi, Romeo Romagnoli, Maria Giovanna Pavani, et al.
Bioorganic & Medicinal Chemistry|December 14, 2001
Antimicrobial and antitumor activity of N-heteroimmine-1,2,3-dithiazoles and their transformation in triazolo-, imidazo-, and pyrazolopirimidinesPier Giovanni Baraldi, Maria Giovanna Pavani, Maria del Carmen Nuñez, et al.
Expert Opinion on Therapeutic Targets|April 16, 2008
The P2X7 receptor as a therapeutic targetRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Neuropharmacology|February 4, 2014
TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in miceFabrizio Vincenzi, Martina Targa, Romeo Romagnoli, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Brain Research|January 31, 2006
The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemiaAlessia Melani, Marco Gianfriddo, Maria Giuliana Vannucchi, et al.
European Journal of Medicinal Chemistry|March 30, 2013
Anticancer activity of novel hybrid molecules containing 5-benzylidene thiazolidine-2,4-dioneRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Handbook of Experimental Pharmacology|July 30, 2009
Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineeringKenneth A Jacobson, Athena M Klutz, Dilip K Tosh, et al.
Journal of Medicinal Chemistry|June 14, 2011
Convergent synthesis and biological evaluation of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as microtubule targeting agentsRomeo Romagnoli, Pier Giovanni Baraldi, Andrea Brancale, et al.
Molecular Pharmacology|January 26, 2002
A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical studyStefania Gessi, Katia Varani, Stefania Merighi, et al.
European Journal of Medicinal Chemistry|May 24, 2015
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH)Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.
Bioorganic & Medicinal Chemistry|March 12, 2002
Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activityPier Giovanni Baraldi, Romeo Romagnoli, Maria Giovanna Pavani, et al.
Bioorganic & Medicinal Chemistry|December 14, 2001
Antimicrobial and antitumor activity of N-heteroimmine-1,2,3-dithiazoles and their transformation in triazolo-, imidazo-, and pyrazolopirimidinesPier Giovanni Baraldi, Maria Giovanna Pavani, Maria del Carmen Nuñez, et al.
Expert Opinion on Therapeutic Targets|April 16, 2008
The P2X7 receptor as a therapeutic targetRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Neuropharmacology|February 4, 2014
TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in miceFabrizio Vincenzi, Martina Targa, Romeo Romagnoli, et al.
Pageof 16